Skip to content
Markets
SPY769.66▲ +0.56%QQQ721.25▲ +1.27%DIA523.28▲ +0.06%GLD372.28▲ +1.21%TLT81.63▼ -0.06%BABA100.24▼ -0.01%NIO3.29▲ +0.92%PDD78.40▲ +0.35%Realtime derived data
Octans ResearchOCTANS RESEARCHWaitlist
A Wall Street street sign in front of the flag-hung facade of the New York Stock Exchange.
Source: Billie Grace Ward, CC0, via Wikimedia Commons

Korro Bio 10% owner Lynx1 Capital Management LP buys $885,000 of shares

Open market purchase reported on Form 4, filed Oct 26, 2026.

Octans ResearchPublished

Snapshot

Lynx1 Capital Management LP, a holder of more than 10% of the shares of Korro Bio (KRRO), bought 79,809 shares in open market purchases between Oct 22, 2026 and Oct 26, 2026, about $885,000 at an average price of $11.09 a share, according to a Form 4 filed with the SEC on Oct 26, 2026.

Coverage
Independent Research
Prepared by
Octans Research
Tickers
KRRO
As of

Market Data

Latest prices for the companies covered in this article
Company1D %Price
($KRRO)▲ +10.65%13.30

as of 16:00 ET · Realtime derived data

What We Know

The filing lists 4 open market purchase lines: • Oct 22, 2026: 12,175 shares at $9.68. • Oct 22, 2026: 40,000 shares at $11.04. • Oct 23, 2026: 2,510 shares at $12.11. • Oct 26, 2026: 25,124 shares at $11.75.

After the last purchase, the filing reports 1,624,789 shares held indirectly in that account.

Octans View

The purchases raised the holding reported in that account by about 5.2%, computed from the filed share counts. An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought. The filing is a joint filing with 1 related reporting person; the purchases are counted once.

Bear Case · Room for Disagreement

Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.

Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.

Chart

$KRRO adjusted close, last 6 months $KRRO adjusted close, last 6 months: series falling from 13.6 to 13.3 (−2%) from 2026-05-01 to 2026-10-27. Scale 8 to 16. 810121416 2026-05-012026-10-27 $KRRO ADJUSTED CLOSE, LAST 6 MONTHS −2% 13.3
Source: Tiingo · As of 2026-10-27Indicative, not investment advice.

Sources

  1. [1]SEC EDGAR — Form 4 filed by Lynx1 Capital Management LP for Korro Bio, Oct 26, 2026

These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.

10%

Lynx1 Capital Management LP, a holder of more than 10% of the shares of Korro Bio (KRRO), bough… · Snapshot

Related coverage

More on $KRRO

4 reports